<?xml version="1.0" encoding="UTF-8"?><xmi:XMI xmlns:tcas="http:///uima/tcas.ecore" xmlns:xmi="http://www.omg.org/XMI" xmlns:cas="http:///uima/cas.ecore" xmlns:types="http:///fr/inra/maiage/bibliome/alvisnlp/bibliomefactory/modules/uima/types.ecore" xmi:version="2.0">
    <cas:NULL xmi:id="0"/>
    <tcas:DocumentAnnotation xmi:id="8" sofa="1" begin="0" end="1934" language="x-unspecified"/>
    <types:DocumentProxy xmi:id="13" sofa="1" id="entities.read.Corpuschoice.WOKread.readWoKcorpus284" features="18 21 24 27 30 33 36 39 42 45 48 51 54 57 60 63 66 69 72 75 78 81 84 87 90 93 96 99 102 105 108 111 114 117 120 123 126 129 132 135 138 141 144 147 150 153 156 159 162 165 168 171 174 177 180 183 186 189 192 195 198 201 204 207 210 213 216 219 222 225 228 231 234 237 240 243" sections="324 342 360"/>
    <cas:Sofa xmi:id="1" sofaNum="1" sofaID="_InitialView" mimeType="text" sofaString="Over-expression of fHbp in Arabdopsis for development of meningococcal&#10;serogroup B subunit vaccineDue to lack of commercial vaccine against the serogroup B (MenB) of Neisseria meningitides, the incidence of meningococcal disease remains high. To solve the issue, transgenic plants are used as bioreactors to produce a plant-derived fHbp subunit vaccine. In this study, the fHbp gene was optimized according to the codon usage bias of Arabidopsis thaliana, synthesized artificially, cloned into an expression vector, driven by a seed-specific promoter, and introduced into A. thaliana by Agrobacterium-mediated floral-dip transformation. Transgenic plants were identified by glufosinate selection, quickstix strips for PAT/bar tests and PCR analysis. The five plants showing higher expression of recombinant fHbp were screened through indirect ELISA. Southern blot analysis showed that the transgenic line rHF-22 had a single-copy integration and the highest expression of fHbp. Recombinant fHbp was purified from seeds of rHF-22 by nitrilotriacetic acid-mediated affinity chromatography, and the purity was 82.5%. BALB/c mice were tested for fHbp vaccine protection from lethal MenB infection, and the relative percent survival was found to be 80%. This study indicates that the recombinant fHbp produced from seeds of rHF-22 is a potential candidate for commercial MenB vaccine. It also provides a reference for safe, cheap and large-scale production of other plant-made vaccines.This study was supported by funds from National Natural Science&#10;Foundation of China (NSFC31271535 and NSFC31501235), Jilin Science&#10;Technology Foundation (JLSTF20130206013YY), and The second batch of the&#10;priority among priorities of a discipline project &quot;Zhejiang province&#10;pharmaceutical priority among priorities disciplines (Wenzhou Medical&#10;University)&quot; of Zhejiang Education Department &quot;The Twelfth Five-year&#10;Plan&quot; (Zhejiang High Education [2014] 21#)"/>
    <types:FeatureProxy xmi:id="18" key="source" value="wok"/>
    <types:FeatureProxy xmi:id="21" key="url" value="https://doi.org/"/>
    <types:FeatureProxy xmi:id="24" key="url" value="https://doi.org/10.1002/biot.201500656"/>
    <types:FeatureProxy xmi:id="27" key="publication-type" value="J"/>
    <types:FeatureProxy xmi:id="30" key="AU" value="Xu, N"/>
    <types:FeatureProxy xmi:id="33" key="AU" value="Wang, YP"/>
    <types:FeatureProxy xmi:id="36" key="AU" value="Ma, JS"/>
    <types:FeatureProxy xmi:id="39" key="AU" value="Jin, LB"/>
    <types:FeatureProxy xmi:id="42" key="AU" value="Xing, SC"/>
    <types:FeatureProxy xmi:id="45" key="AU" value="Jiang, C"/>
    <types:FeatureProxy xmi:id="48" key="AU" value="Li, XK"/>
    <types:FeatureProxy xmi:id="51" key="AF" value="Xu, Nuo"/>
    <types:FeatureProxy xmi:id="54" key="AF" value="Wang, Yunpeng"/>
    <types:FeatureProxy xmi:id="57" key="AF" value="Ma, Jisheng"/>
    <types:FeatureProxy xmi:id="60" key="AF" value="Jin, Libo"/>
    <types:FeatureProxy xmi:id="63" key="AF" value="Xing, Shaochen"/>
    <types:FeatureProxy xmi:id="66" key="AF" value="Jiang, Chao"/>
    <types:FeatureProxy xmi:id="69" key="AF" value="Li, Xiaokun"/>
    <types:FeatureProxy xmi:id="72" key="SO" value="BIOTECHNOLOGY JOURNAL"/>
    <types:FeatureProxy xmi:id="75" key="LA" value="English"/>
    <types:FeatureProxy xmi:id="78" key="DT" value="Article"/>
    <types:FeatureProxy xmi:id="81" key="DE" value="Arabidopsis thaliana"/>
    <types:FeatureProxy xmi:id="84" key="DE" value="fHbp"/>
    <types:FeatureProxy xmi:id="87" key="DE" value="Neisseria meningitides serogroup B (MenB)"/>
    <types:FeatureProxy xmi:id="90" key="DE" value="Plant-derived subunit vaccine"/>
    <types:FeatureProxy xmi:id="93" key="ID" value="FACTOR-H-BINDING"/>
    <types:FeatureProxy xmi:id="96" key="ID" value="NEISSERIA-MENINGITIDIS"/>
    <types:FeatureProxy xmi:id="99" key="ID" value="ARABIDOPSIS-THALIANA"/>
    <types:FeatureProxy xmi:id="102" key="ID" value="PROTEIN"/>
    <types:FeatureProxy xmi:id="105" key="ID" value="METHIONINE"/>
    <types:FeatureProxy xmi:id="108" key="ID" value="PLANT"/>
    <types:FeatureProxy xmi:id="111" key="ID" value="ACCUMULATION"/>
    <types:FeatureProxy xmi:id="114" key="ID" value="PURIFICATION"/>
    <types:FeatureProxy xmi:id="117" key="ID" value="LIPOPROTEIN"/>
    <types:FeatureProxy xmi:id="120" key="ID" value="ANTIBODIES"/>
    <types:FeatureProxy xmi:id="123" key="ID" value="entities.read.Corpuschoice.WOKread.readWoKcorpus284"/>
    <types:FeatureProxy xmi:id="126" key="C1" value="[Xu, Nuo; Li, Xiaokun] Jilin Univ, Coll Life Sci, Changchun 130021, Peoples R China."/>
    <types:FeatureProxy xmi:id="129" key="C1" value="[Wang, Yunpeng; Xing, Shaochen] Jilin Acad Agr Sci, Agro Biotechnol Res Inst, Changchun, Peoples R China."/>
    <types:FeatureProxy xmi:id="132" key="C1" value="[Xu, Nuo; Wang, Yunpeng; Jin, Libo; Jiang, Chao; Li, Xiaokun] Wenzhou Univ, Wenzhou, Peoples R China."/>
    <types:FeatureProxy xmi:id="135" key="C1" value="[Wang, Yunpeng; Ma, Jisheng; Jin, Libo; Jiang, Chao; Li, Xiaokun] Wenzhou Med Univ, Sch Pharmaceut Sci, Zhejiang Key Lab Biotechnol &amp; Pharmaceut Engn, Wenzhou, Peoples R China."/>
    <types:FeatureProxy xmi:id="138" key="RP" value="Li, XK (reprint author), Jilin Univ, Coll Life Sci, Changchun 130021, Peoples R China.; Jiang, C (reprint author), Wenzhou Med Univ, Sch Pharmaceut Sci, Chashan Coll Pk, Wenzhou 325035, Peoples R China."/>
    <types:FeatureProxy xmi:id="141" key="EM" value="chaojiang10@hotmail.com; proflxk@163.com"/>
    <types:FeatureProxy xmi:id="144" key="FU" value="National Natural Science Foundation of China [NSFC31271535,"/>
    <types:FeatureProxy xmi:id="147" key="FU" value="NSFC31501235]; Jilin Science Technology Foundation [JLSTF20130206013YY];"/>
    <types:FeatureProxy xmi:id="150" key="FU" value="second batch of the priority among priorities of a discipline project"/>
    <types:FeatureProxy xmi:id="153" key="FU" value="Zhejiang province pharmaceutical priority among priorities disciplines"/>
    <types:FeatureProxy xmi:id="156" key="FU" value="(Wenzhou Medical University)&quot; o [[2014] 21]"/>
    <types:FeatureProxy xmi:id="159" key="NR" value="39"/>
    <types:FeatureProxy xmi:id="162" key="TC" value="0"/>
    <types:FeatureProxy xmi:id="165" key="Z9" value="0"/>
    <types:FeatureProxy xmi:id="168" key="U1" value="5"/>
    <types:FeatureProxy xmi:id="171" key="U2" value="5"/>
    <types:FeatureProxy xmi:id="174" key="PU" value="WILEY-V C H VERLAG GMBH"/>
    <types:FeatureProxy xmi:id="177" key="PI" value="WEINHEIM"/>
    <types:FeatureProxy xmi:id="180" key="PA" value="POSTFACH 101161, 69451 WEINHEIM, GERMANY"/>
    <types:FeatureProxy xmi:id="183" key="SN" value="1860-6768"/>
    <types:FeatureProxy xmi:id="186" key="EI" value="1860-7314"/>
    <types:FeatureProxy xmi:id="189" key="J9" value="BIOTECHNOL J"/>
    <types:FeatureProxy xmi:id="192" key="JI" value="Biotechnol. J."/>
    <types:FeatureProxy xmi:id="195" key="PD" value="JUL"/>
    <types:FeatureProxy xmi:id="198" key="PY" value="2016"/>
    <types:FeatureProxy xmi:id="201" key="VL" value="11"/>
    <types:FeatureProxy xmi:id="204" key="IS" value="7"/>
    <types:FeatureProxy xmi:id="207" key="BP" value="973"/>
    <types:FeatureProxy xmi:id="210" key="EP" value="980"/>
    <types:FeatureProxy xmi:id="213" key="DI" value="10.1002/biot.201500656"/>
    <types:FeatureProxy xmi:id="216" key="PG" value="8"/>
    <types:FeatureProxy xmi:id="219" key="WC" value="Biochemical Research Methods"/>
    <types:FeatureProxy xmi:id="222" key="WC" value="Biotechnology &amp; Applied Microbiology"/>
    <types:FeatureProxy xmi:id="225" key="SC" value="Biochemistry &amp; Molecular Biology"/>
    <types:FeatureProxy xmi:id="228" key="SC" value="Biotechnology &amp; Applied Microbiology"/>
    <types:FeatureProxy xmi:id="231" key="GA" value="DR3EZ"/>
    <types:FeatureProxy xmi:id="234" key="UT" value="WOS:000379786700012"/>
    <types:FeatureProxy xmi:id="237" key="PM" value="27119621"/>
    <types:FeatureProxy xmi:id="240" key="identifiant" value="entities.read.Corpuschoice.WOKread.readWoKcorpus284"/>
    <types:FeatureProxy xmi:id="243" key="doi" value="10.1002/biot.201500656"/>
    <types:SectionProxy xmi:id="324" sofa="1" begin="0" end="98" name="TI" features="332" layers="" relations=""/>
    <types:FeatureProxy xmi:id="332" key="sectionname" value="title"/>
    <types:SectionProxy xmi:id="342" sofa="1" begin="98" end="1481" name="AB" features="350" layers="" relations=""/>
    <types:FeatureProxy xmi:id="350" key="sectionname" value="abstract"/>
    <types:SectionProxy xmi:id="360" sofa="1" begin="1481" end="1934" name="FX" features="" layers="" relations=""/>
    <cas:View sofa="1" members="8 13"/>
</xmi:XMI>
